NLM-001

N/A

Report date: 2026/05/12 20:00:17
NME

Base Information

Drug NameNLM-001
Drug Alias NameNLM-001TAK-441
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSonic Hedgehog Homolog inhibitors
TargetsSonic Hedgehog Homolog
Therapy Area/IndicationsPancreatic NeoplasmsCarcinoma, Basal CellCarcinoma, Pancreatic Ductal +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSpain
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMillennium Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesNelum Corp
Inactive CompaniesMillennium Pharmaceuticals Inc
Active IndicationsPancreatic NeoplasmsCarcinoma, Pancreatic Ductal
Inactive IndicationsCarcinoma, Basal CellNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A